By otakuyassine3@gmail.com 
O Shaughnessy Asset Management LLC raised its position in Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 3.0% during the fourth quarter, HoldingsChannel reports. The firm owned 7,026 shares of the company’s stock after buying an additional 207 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Prestige Consumer Healthcare were worth $549,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the company. Allspring Global Investments Holdings LLC increased its position in shares of Prestige Consumer Healthcare by 3.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock valued at $126,274,000 after purchasing an additional 49,331 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Prestige Consumer Healthcare by 4.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock valued at $95,678,000 after purchasing an additional 50,961 shares during the last quarter. Congress Asset Management Co. increased its position in shares of Prestige Consumer Healthcare by 5.0% in the 4th quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock valued at $70,964,000 after purchasing an additional 43,619 shares during the last quarter. Boston Trust Walden Corp increased its position in shares of Prestige Consumer Healthcare by 43.5% in the 4th quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock valued at $64,942,000 after purchasing an additional 252,089 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Prestige Consumer Healthcare by 5.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company’s stock valued at $49,667,000 after buying an additional 33,844 shares during the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.
Prestige Consumer Healthcare Trading Up 4.4 %
Shares of PBH stock opened at $83.35 on Thursday. The company has a market capitalization of $4.13 billion, a P/E ratio of 19.52, a price-to-earnings-growth ratio of 2.69 and a beta of 0.47. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The business’s 50 day moving average is $84.33 and its two-hundred day moving average is $79.69. Prestige Consumer Healthcare Inc. has a twelve month low of $62.35 and a twelve month high of $90.04.
Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the stock. DA Davidson increased their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Canaccord Genuity Group increased their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Oppenheimer increased their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Finally, StockNews.com downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $93.33.
Read Our Latest Stock Analysis on Prestige Consumer Healthcare
Insider Transactions at Prestige Consumer Healthcare
In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the sale, the senior vice president now owns 17,157 shares of the company’s stock, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.60% of the company’s stock.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Recommended Stories
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report).
Receive News & Ratings for Prestige Consumer Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.